← Back
$TVTX All transactions

Travere Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$8K

Shares

470

Price

$17

Filed

Aug 28

Insider

Name

Cline Christopher R.

Title

CHIEF FINANCIAL OFFICER

CIK

0001943192

Roles

Officer

Transaction Details

Transaction Date

2025-08-27

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

92,656

Footnotes

This sale was made pursuant to a written plan adopted on May 28, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of additional shares to cover the tax obligation that occurred upon the vesting of performance-based restricted stock units (PSUs) that vested in May 2025.

Filing Info

Accession No.

0001415889-25-023209

Form Type

4

Issuer CIK

0001438533

Cline Christopher R.'s History

Date Ticker Type Value
2026-04-15 TVTX $43K
2026-04-14 TVTX $370
2026-04-14 TVTX $304K
2026-04-13 TVTX A $0
2026-04-13 TVTX $2K
2025-12-01 TVTX M $325K
2025-12-01 TVTX $700K
2025-12-01 TVTX M $0
2025-09-04 TVTX $2K
2025-09-03 TVTX $8K

Other Insiders at TVTX (90d)

Insider Bought Sold Last
LYONS GARY A $329K 2026-04-14
REED ELIZABETH E
Chief Legal Officer and GC
$2.1M 2026-04-15
REED ELIZABETH E / Heerma Peter / Inrig Jula
Chief Legal Officer and GC
$303K 2026-04-14
Baynes Roy D. $1.7M 2026-04-14
ROTE WILLIAM E.
Chief Research Officer
$356K 2026-04-22
Dube Eric M
CHIEF EXECUTIVE OFFICER
$6.3M 2026-04-15
Heerma Peter
CHIEF COMMERCIAL OFFICER
2026-04-13
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
$903K 2026-04-14
Inrig Jula
CHIEF MEDICAL OFFICER
$43K 2026-04-15
Cline Christopher R.
CHIEF FINANCIAL OFFICER
$349K 2026-04-15